» Articles » PMID: 38660400

Hypoxia Stimulates CTC-platelet Cluster Formation to Promote Breast Cancer Metastasis

Overview
Journal iScience
Publisher Cell Press
Date 2024 Apr 25
PMID 38660400
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating tumor cell clusters/micro-emboli (CTM) possess greater metastatic capacity and survival advantage compared to individual circulating tumor cell (CTC). However, the formation of CTM subtypes and their role in tumor metastasis remain unclear. In this study, we used a microfluidic Cluster-Chip with easy operation and high efficiency to isolate CTM from peripheral blood, which confirmed their correlation with clinicopathological features and identified the critical role of CTC-platelet clusters in breast cancer metastasis. The correlation between platelets and CTM function was further confirmed in a mouse model and RNA sequencing of CTM identified high-expressed genes related to hypoxia stimulation and platelet activation which possibly suggested the correlation of hypoxia and CTC-platelet cluster formation. In conclusion, we successfully developed the Cluster-Chip platform to realize the clinical capture of CTMs and analyze the biological properties of CTC-platelet clusters, which could benefit the design of potential treatment regimens to prevent CTM-mediated metastasis and tumor malignant progression.

Citing Articles

Molecular Underpinnings of Brain Metastases.

Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y Int J Mol Sci. 2025; 26(5).

PMID: 40076927 PMC: 11900073. DOI: 10.3390/ijms26052307.


The Dynamic Landscape of the Coagulome of Metastatic Malignant Melanoma.

Arnault J, Chemmama K, Ferroudj K, Demagny J, Panicot-Dubois L, Galmiche A Int J Mol Sci. 2025; 26(4).

PMID: 40003901 PMC: 11855523. DOI: 10.3390/ijms26041435.


The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy.

Morales-Pacheco M, Valenzuela-Mayen M, Gonzalez-Alatriste A, Mendoza-Almanza G, Cortes-Ramirez S, Losada-Garcia A Biomark Res. 2025; 13(1):27.

PMID: 39934930 PMC: 11818056. DOI: 10.1186/s40364-025-00742-w.

References
1.
Ward M, Kane L, Norris L, Mohamed B, Kelly T, Bates M . Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?. Mol Cancer. 2021; 20(1):59. PMC: 8011144. DOI: 10.1186/s12943-021-01347-1. View

2.
Kulasinghe A, Zhou J, Kenny L, Papautsky I, Punyadeera C . Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips. Cancers (Basel). 2019; 11(1). PMC: 6356955. DOI: 10.3390/cancers11010089. View

3.
Li Y, Tian X, Gao L, Jiang X, Fu R, Zhang T . Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer. Cancer Med. 2019; 8(8):3782-3792. PMC: 6639255. DOI: 10.1002/cam4.2286. View

4.
Jarvas G, Guttman A . Modeling of cell sorting and rare cell capture with microfabricated biodevices. Trends Biotechnol. 2013; 31(12):696-703. DOI: 10.1016/j.tibtech.2013.10.001. View

5.
Ge X, Zhang W, Zhu T, Huang N, Yao M, Liu H . Hypoxia-activated platelets stimulate proliferation and migration of pulmonary arterial smooth muscle cells by phosphatidylserine/LOX-1 signaling-impelled intercellular communication. Cell Signal. 2021; 87:110149. DOI: 10.1016/j.cellsig.2021.110149. View